These benefits, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a unique technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-relevant Diseases. These benefits suggest that conolidine https://giordanoh124oyr0.wikitron.com/user